Related references
Note: Only part of the references are listed.Temporal relationship of peroxymtrite-induced oxidative damage, calpain-mediated cytoskeletal degradation and neurodegeneration after traumatic brain injury
Ying Deng et al.
EXPERIMENTAL NEUROLOGY (2007)
Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury
Jimmi Hatton et al.
JOURNAL OF NEUROSURGERY (2006)
Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy
Indrapal N. Singh et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)
Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice
Stephanie N. Thompson et al.
EXPERIMENTAL NEUROLOGY (2006)
Evaluation of pharmacological treatment strategies in traumatic brain injury
Niklas Marklund et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Cyclosporin A disposition following acute traumatic brain injury
PE Empey et al.
JOURNAL OF NEUROTRAUMA (2006)
Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial
AIR Maas et al.
LANCET NEUROLOGY (2006)
A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist anatibant (LF16-0687Ms) in patients with severe traumatic brain injury
A Marmarou et al.
JOURNAL OF NEUROTRAUMA (2005)
The public health approach to traumatic brain injury - An overview of CDC's research and programs
S Binder et al.
JOURNAL OF HEAD TRAUMA REHABILITATION (2005)
Update of neuropathology and neurological recovery after traumatic brain injury
JT Povlishock et al.
JOURNAL OF HEAD TRAUMA REHABILITATION (2005)
Mitochondrial permeability transition in CNS trauma: Cause or effect of neuronal cell death?
PG Sullivan et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Experimental models of traumatic brain injury: Do we really need to build a better mousetrap?
DM Morales et al.
NEUROSCIENCE (2005)
Neuroprotection by cyclosporin A following transient brain ischemia correlates with the inhibition of the early efflux of cytochrome C to cytoplasm
K Domañska-Janik et al.
MOLECULAR BRAIN RESEARCH (2004)
The protective effect of Cyclosporin A upon N-acetylaspartate and mitochondrial dysfunction following experimental diffuse traumatic brain injury
S Signoretti et al.
JOURNAL OF NEUROTRAUMA (2004)
Mitochondrial damage and dysfunction in traumatic brain injury
J Lifshitz et al.
MITOCHONDRION (2004)
Mitochondrial uncoupling as a therapeutic target following neuronal injury
PG Sullivan et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2004)
The mitochondrial permeability transition as a target for neuroprotection
BS Kristal et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2004)
Proteins released from degenerating neurons are surrogate markers for acute brain damage
R Siman et al.
NEUROBIOLOGY OF DISEASE (2004)
Peroxynitrite-mediated protein nitration and lipid peroxidation in a mouse model of traumatic brain injury
ED Hall et al.
JOURNAL OF NEUROTRAUMA (2004)
Downregulation of amyloid precursor protein (APP) expression following post-traumatic cyclosporin-A administration
C Van den Heuvel et al.
JOURNAL OF NEUROTRAUMA (2004)
Molecular mechanisms of neuroprotective action of immuno suppress ants - facts and hypotheses
B Kaminska et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2004)
Differential effects of traumatic brain injury on the cytochrome P450 system: A perspective into hepatic and renal drug metabolism
A Kalsotra et al.
JOURNAL OF NEUROTRAUMA (2003)
Brain edema induced by in vitro ischemia:: causal factors and neuroprotection
DG MacGregor et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Pharmacology of traumatic brain injury
NC Royo et al.
CURRENT OPINION IN PHARMACOLOGY (2003)
Immunophilins in nervous system degeneration and regeneration
M Avramut et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2003)
Bradykinin receptor agonist facilitates low-dose Cyclosporine-A protection against 6-hydroxydopamine neurotoxicity
CV Borlongan et al.
BRAIN RESEARCH (2002)
Expression profiling following traumatic brain injury: A review
PG Marciano et al.
NEUROCHEMICAL RESEARCH (2002)
Cytochrome c release and caspase activation after traumatic brain injury
PG Sullivan et al.
BRAIN RESEARCH (2002)
Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition
H Uchino et al.
NEUROBIOLOGY OF DISEASE (2002)
Cyclosporin A improves brain tissue oxygen consumption and learning/memory performance after lateral fluid percussion injury in rats
B Alessandri et al.
JOURNAL OF NEUROTRAUMA (2002)
Clinical trials in head injury
RK Narayan et al.
JOURNAL OF NEUROTRAUMA (2002)
Local and systemic increase in lipid peroxidation after moderate experimental traumatic brain injury
D Pratico et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Current aspects of pathophysiology and cell dysfunction after severe head injury
J Sahuquillo et al.
CURRENT PHARMACEUTICAL DESIGN (2001)
Pharmacological treatment of traumatic brain injury - A review of agents in development
J Hatton
CNS DRUGS (2001)
Apoptosis after traumatic brain injury
R Raghupathi et al.
JOURNAL OF NEUROTRAUMA (2000)
Free radical pathways in CNS injury
A Lewén et al.
JOURNAL OF NEUROTRAUMA (2000)
Cyclosporin ameliorates traumatic brain-injury-induced alterations of hippocampal synaptic plasticity
BC Albensi et al.
EXPERIMENTAL NEUROLOGY (2000)
Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury
PG Sullivan et al.
EXPERIMENTAL NEUROLOGY (2000)
Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats
PG Sullivan et al.
NEUROSCIENCE (2000)
Share Paper
